|
R. Gordon Douglas, Jr., M.D., President, Merck Vaccines (Retired)
Dr. Douglas has served as a Director since January 2003. Dr. Douglas was President of Merck Vaccines, responsible for the research, development, manufacturing, and marketing of Merck's vaccine products until May 1999. He grew the vaccine business from $300 million to $1.2 billion, launched four new products, invested heavily in manufacturing facilities as well as research and development, and expanded the business globally. Prior to joining Merck in 1989, Dr. Douglas had a distinguished career as a physician and academician, specializing in infectious diseases. From 1982 to 1990, he was a Professor of Medicine and Chairman of the Department of Medicine at Cornell University Medical College and Physician in Chief of New York Hospital. He also served as Head of the Infectious Disease Unit at the University of Rochester School of Medicine. Dr. Douglas currently acts as Consultant to the Vaccine Research Center at the National Institute of Health and serves on the Boards of Directors of several biotech companies and non-profits interested in vaccines and world health. Dr. Douglas is a graduate of Princeton University and Cornell University Medical College. He received his medical staff training at New York Hospital and Johns Hopkins Hospital. | 